Antibiotic Dosing in Geriatric Patients At the Emergency Department

Recruiting Observational Study
Elderly Infection Frailty Frail Elderly Syndrome Infection, Bacterial
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
75 and older
Sex
Any
Study type
Observational
Participants needed
180 (estimated)
Sponsor
University Hospital, Ghent · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

In this pilot study, we will investigate whether - with the current dosing regimens, used in the Ghent University Hospital - pharmacodynamic targets regarding beta-lactam antibiotics (more specific Amoxicilline-Clavulanate, Piperacillin-Tazobactam and Temocillin) are attained in frail patients admitted to the geriatric department.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients presenting at the emergency department and later on admitted to the geriatric department * Patient age 75 years or older * Patients with geriatric profile according to KATZ scale, G8 screening test or CIRS score. * Patient receiving antibiotic treatment (amoxicillin-c…
Contacts

Peter De Paepe, Prof. Dr.

003293325211

peter.depaepe@uzgent.be

CONTACT

Tania Desmet, Dr.

003293321559

tania.desmet@uzgent.be

CONTACT